Security key
00972D105
Akebia Therapeutics, Inc. - COMMON STOCK (AKBA)
CUSIP: 00972D105
Q2 2025 13F Holders as of 30 Jun 2025
- Security type / class
- Equity / COMMON STOCK
- Total 13F shares
- 108,291,108
- Total 13F value
- $394,183,978
- Share change
- +12,527,818
- Put/Call ratio
- 196%
- SEC-reported price per share
- $3.64
- Number of holders
- 157
- Value change
- +$56,486,637
- Number of buys
- 109
- Number of sells
- 41
- Shares outstanding
- 270,093,163
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2025
Institutions
157
Top holders
10
AKBA full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2025
Previous quarter: Q1 2025
Akebia Therapeutics, Inc. SEC filings
Akebia Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 00972D105
Recent filing periods:
Ownership snapshot
Top reported holders of AKBA - Akebia Therapeutics, Inc. - COMMON STOCK (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Satter Muneer A.
Disclosed value leader
BlackRock, Inc.
Comparable rows
15/15
Latest evidence
31 Mar 2025
13D/G
13F
Lead comparable stake: 2.6%
13D/G row: Satter Muneer A.
Showing 1-6 of 15 holder rows.
Quick read
Satter Muneer A. leads the comparable SEC ownership view at 2.6%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Satter Muneer A.'s linked filing trail.
Comparable ownership
Top 5
Satter Muneer A.
2.6%
BlackRock, Inc.
5.7%
VANGUARD GROUP INC
4.7%
STATE STREET CORP
2.5%
GEODE CAPITAL MANAGEMENT, LLC
1.9%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Satter Muneer A. |
13D/G
|
2.6%
|
$13,105,226
5,747,906 shares
|
$0 | 31 Dec 2024 |
| BlackRock, Inc. |
13F
Company
|
5.7%
|
$29,437,752
15,332,163 shares
|
— | 31 Mar 2025 |
| VANGUARD GROUP INC |
13F
Company
|
4.7%
|
$24,356,741
12,685,803 shares
|
— | 31 Mar 2025 |
| STATE STREET CORP |
13F
Company
|
2.5%
|
$13,067,149
6,805,807 shares
|
— | 31 Mar 2025 |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
Company
|
1.9%
|
$9,661,509
5,030,740 shares
|
— | 31 Mar 2025 |
| GREAT POINT PARTNERS LLC |
13F
Company
|
1.8%
|
$9,549,773
4,973,840 shares
|
— | 31 Mar 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
157
Shares
108,291,108
Rows available
157
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2025 vs Q1 2025 Across Filers
Q1 2025 holders
142
Q2 2025 holders
157
Holder diff
15
| Investor | Q1 2025 Shares | Q2 2025 Shares | Share Diff | Share Chg % | Q1 2025 value | Q2 2025 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend